Long COVID Atlas
Text Theme
Note

Education, not medical advice. Do not start, stop, or change any medication or supplement without your own clinician, who knows your history and other medicines.

Treatment · Autonomic

Beta-blockers (propranolol, bisoprolol)

When the heart races on standing, a low-dose beta-blocker can take the edge off. Used carefully, propranolol and similar drugs reduce the standing heart-rate surge and the palpitations that come with POTS.

Short version: low-dose beta-blockers slow the standing heart-rate surge in POTS. A mainstay option, but dose matters and they can lower blood pressure or add fatigue.

Slowing the racing heart

Low-dose beta-blockers (such as propranolol or bisoprolol) blunt the heart-rate surge on standing, easing palpitations and the sense of the heart pounding in POTS.1

What standing up does Lying downheart rate about 72,blood spread evenly stand up Standingblood pools in the legs;to compensate the heartraces 30+ beats faster POTS = the racing heart on standing;orthostatic intolerance = dizzy, foggy, faint upright
Standing is a small cardiovascular stress test. Gravity pulls blood into the legs, and the body must tighten vessels and adjust heart rate to keep the brain supplied. When that reflex misfires, the heart compensates by racing (POTS) and the brain is briefly under-supplied, felt as dizziness, lightheadedness, and fog on standing.

What the evidence says

Across POTS trials, low-dose propranolol reduces standing heart rate and symptoms; reviews place beta-blockers among the mainstay options, with similar signals in post-COVID POTS. Higher doses are less well tolerated.2, 3

mainstay option dose matters

Cautions

Beta-blockers can lower blood pressure and worsen fatigue or breathing in some people, so they are started low and titrated. They are one tool inside a broader plan that includes fluids, salt, and pacing.

What we don't know

Honest about the edges of the evidence. These are open questions, not settled answers.

  • Which beta-blocker is best for POTS, which is undersettled.
  • How they compare with ivabradine head-to-head.
  • Who tolerates them and who does not.

References

Every reference is free to read in full.

  1. POTS and dysautonomia after COVID-19 (review of management).
  2. Oral medications for POTS, including PASC-associated POTS (systematic review).
  3. Treatment of POTS: non-pharmacological and pharmacological (systematic review).

Associated topics